Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Asthma Allergy Immunology is Scopus-indexed (Q3, CiteScore 1.3), WoS ESCI. Published by Turkish National Society of Allergy and Clinical Immunology.
Checked against the index lists dated .
ISSN 1308-9234Verify ISSN ↗
Publisher: Turkish National Society of Allergy and Clinical Immunology
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Pulmonary and Respiratory Medicine | 123 / 165 | 25th | Q3 |
| Immunology and Allergy | 192 / 234 | 18th | Q4 |
| Immunology | 210 / 243 | 13th | Q4 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2019–present (also 2014–2016), best quartile Q3, CiteScore 1.3.
Asthma Allergy Immunology is Q3 in Pulmonary and Respiratory Medicine (rank 123 of 165), Q4 in Immunology and Allergy (rank 192 of 234) and Q4 in Immunology (rank 210 of 243), by CiteScore 2025.
Asthma Allergy Immunology is indexed in the Emerging Sources Citation Index, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 1.3, which places it in quartile Q3 at the 25th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.170, quartile Q4, with an H-index of 6.
Asthma Allergy Immunology is published by Turkish National Society of Allergy and Clinical Immunology. Its ISSN is 1308-9234.
Yes — indexed in the Emerging Sources Citation Index.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Asthma Allergy Immunology has an h-index of 7 and a 2-year mean of 0.58 citations per paper (OpenAlex). Its Scopus CiteScore is 1.3, quartile Q3. On 2-year citations it ranks #124 of 160 Scopus journals in Pulmonary and Respiratory Medicine.
Asthma Allergy Immunology published 49 papers in 2025; its busiest recent year was 2024 with 49. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 95 research articles (2024–2026), authors are most often from Türkiye (78.2%), Antigua & Barbuda (3.9%) and Cambodia (3.7%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.